Back to search

Article

Bortezomib-Induced Skin Eruption in Patient with Newly Diagnosed Multiple Myeloma under VRd Regime: A Case Report

2025-07-18

Abstract excerpt

<title>Abstract</title> <p>The proteasome inhibitor bortezomib is used to treat various hematological cancers. It is currently included in the standard of care for individuals receiving their first line treatment for a recently diagnosed multiple myeloma. Generally well tolerated, bortezomib has been linked to a number of side effects. In this instance, a reticular eruption that developed at the site of a subcuta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f42b415-3a39-5b75-94c3-93f933508e8a
DOI
10.21203/rs.3.rs-7124847/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bortezomib-Induced Skin Eruption in Patient with Newly Diagnosed Multiple Myeloma under VRd Regime: A Case ReportDOI 10.21203/rs.3.rs-7124847/v1
Select a neighboring publication to make it the new centre.